Polyurethanes as self adhesive matrix for the transdermal drug delivery of testosterone

References

• Bovell L. (2010). Novartis leads $5.6 billion transdermal delivery market, summary of the report: advances in the transdermal drug delivery market: market size, leading players, therapeutic focus and innovative technologies. [Online] Available at: http://www.companiesandmarkets.com/news/novartis-leads-56-bn-transdermaldrug-delivery-market-n211.aspx. Accessed on January 25 2011.
   Google Scholar
• Thornton P. (2010). Advances in the Transdermal Drug Delivery Market Market size, leading players, therapeutic focus and innovative technologies. Business Insights Ltd, [Online] Available at: http://www.globalbusinessinsights.com/content/rbdl0004t.pdf. Accessed on January 2011.
   Google Scholar
• Brown MB, Martin GP, Jones SA, Akomeah FK. (2006). Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv, 13:175–187.
   PubMed Web of Science ®Google Scholar
• Klode J, Schöttler L, Stoffels I, Körber A, Schadendorf D, Dissemond J. (2011). Investigation of adhesion of modern wound dressings: a comparative analysis of 56 different wound dressings. J Eur Acad Dermatol Venereol, 25:933–939.
   PubMed Web of Science ®Google Scholar
• Chen X, Liu W, Zhao Y, Jiang L, Xu H, Yang X. (2009). Preparation and characterization of PEG-modified polyurethane pressure-sensitive adhesives for transdermal drug delivery. Drug Dev Ind Pharm, 35:704–711.
   PubMed Web of Science ®Google Scholar
• Shelke NB, Sairam M, Halligudi SB et al. (2007). Development of transdermal drug delivery films with castor-oil-based polyurethanes. J Appl Polym Sci, 103:779–788.
   Web of Science ®Google Scholar
• Cal K, Janicki S, Sznitowska M. (2001). In vitro studies on penetration of terpenes from matrix-type transdermal systems through human skin. Int J Pharm, 224:81–88.
   PubMed Web of Science ®Google Scholar
• Zurdo Schroeder I, Franke P, Schaefer UF, Lehr CM. (2007). Delivery of ethinylestradiol from film forming polymeric solutions across human epidermis in vitro and in vivo in pigs. J Control Release, 118:196–203.
   PubMed Web of Science ®Google Scholar
• Aggarwal G. (2009). Development, fabrication and evaluation of transdermal drug delivery system - a review. Latest Reviews [Online] Available at: http://www.pharmainfo.net/reviews/development-fabrication-and-evaluation-transdermal-drug-delivery-system-review. Accessed on January 2009.
   Google Scholar
• Gansen P, Dittgen M, Steinfatt-Hoffmann I, Schulte C, Henze J; Inventors. (2010). Otto Bock PUR Life Science GmbH, assignee. Polyurethane plaster for the transdermal application of active substances, and method for the production thereof. Patent WO 2010060621 (A1).
   Google Scholar
• Pierre Fabre. (2007).TESTOPATCH, leaflet 010530-Z951. Fachinfo-Service RLSG [August], Berlin, Germany.
   Google Scholar
• Jain P, Banga AK. (2010). Inhibition of crystallization in drug-in-adhesive-type transdermal patches. Int J Pharm, 394:68–74.
   PubMed Web of Science ®Google Scholar
• Zhao H, Lee CH, Chung SJ, Shim CK, Kim DD. (2005). In vitro and in vivo evaluation of a novel nonscrotal matrix-type transdermal delivery system of testosterone. Drug Dev Ind Pharm, 31:257–261.
   PubMed Web of Science ®Google Scholar
• Podhaisky HP, Mellinger U, Moore C. (2005). In vitro- und klinische Untersuchungen zum Unterschied von apothekengefertigten Testosteron-haltigen transdermalen Anwendungsformen und dem Produkt Testogel. Blickpunkt DER MANN, 3:20–24.
   Google Scholar
• Fauth C, Wiedersberg S, Neubert RH, Dittgen M. (2002). Adhesive backing foil interactions affecting the elasticity, adhesion strength of laminates, and how to interpret these properties of branded transdermal patches. Drug Dev Ind Pharm, 28:1251–1259.
   PubMed Web of Science ®Google Scholar
• Mehdizadeh A, Toliate T, Rouini MR, Abashzadeh S, Dorkoosh F. (2004). Design and in vitro evaluation of new drug-in-adhesive formulations of fentanyl transdermal patches. Acta Pharm, 54:301–317.
   PubMedGoogle Scholar
• Pongjanyakul T, Prakongpan S, Priprem A. (2003). Acrylic matrix type nicotine transdermal patches: in vitro evaluations and batch-to-batch uniformity. Drug Dev Ind Pharm, 29:843–853.
   PubMed Web of Science ®Google Scholar
• Aqil M, Ali A. (2002). Monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: in vitro characterisation. Eur J Pharm Biopharm, 54:161–164.
   PubMed Web of Science ®Google Scholar
• Myszka SLW, Husberg ML. (2000). Testosterone in vitro - in vivo correlation. AAPS Pharm Sci, 2, S1 [Online] Available at: http://www.aapsj.org/abstracts/AM_2000/2384.htm. Accessed on January 2011.
   Google Scholar
• Mills PC, Magnusson BM, Cross SE. (2006). The effects of vehicle and region of application on in vitro penetration of testosterone through canine skin. Vet J, 171:276–280.
   PubMed Web of Science ®Google Scholar
• He W, Guo X, Zhang M. (2008). Transdermal permeation enhancement of N-trimethyl chitosan for testosterone. Int J Pharm, 356:82–87.
   PubMed Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13:123–133.
   PubMed Web of Science ®Google Scholar
• Shah JC, Kaka I, Tenjarla S et al. (1994). Analysis of percutaneous permeation data: II.Evaluation of the lag time method. Int J Pharm, 109:283–290.
   Google Scholar
• Gordon RD. (2010). Backing films for transdermal and topical patches - more than pieces of plastic. Transdermal 2:13–23.
   Google Scholar
• Kandavilli S, Nair V, Panchagnula R. (2002). Polymers in transdermal drug delivery systems. Pharm Technol, 28:62–80 [Online] Available at: http://pharmtech.findpharma.com/pharmtech/data/articlestandard//pharmtech/192002/18600/article.pdf. Accessed on January 2011.
   Google Scholar
• Bayer Material Science (2010). Films for ideas, the specialist for high performance films. [Online] Available at: www.bayermaterialscience.com/. Accessed on April 26 2010.
   Google Scholar
• Kim MK, Lee CH, Kim DD. (2000). Skin permeation of testosterone and its ester derivatives in rats. J Pharm Pharmacol, 52:369–375.
   PubMed Web of Science ®Google Scholar
• Kim MK, Zhao H, Lee CH, Kim DD. (2001). Formulation of a reservoir-type testosterone transdermal delivery system. Int J Pharm, 219:51–59.
   PubMed Web of Science ®Google Scholar
• Aqil M, Ahad A, Sultana Y, Ali A. (2007). Status of terpenes as skin penetration enhancers. Drug Discov Today, 12:1061–1067.
   PubMed Web of Science ®Google Scholar
• Ferrante M, Andreeta A, Landoni MF. (2010). Effect of different penetration enhancers on diclofenac permeation across horse skin. Vet J, 186:312–315.
   PubMed Web of Science ®Google Scholar
• Yamato K, Takahashi Y, Akiyama H, Tsuji K, Onishi H, Machida Y. (2009). Effect of penetration enhancers on transdermal delivery of propofol. Biol Pharm Bull, 32:677–683.
   PubMed Web of Science ®Google Scholar
• Song YH, Gwak HS, Chun IK. (2009). The effects of terpenes on the permeation of lidocaine and ofloxacin from moisture-activated patches. Drug Deliv, 16:75–81.
   PubMed Web of Science ®Google Scholar
• Zhao H, Choi MK, Kim JS, Yong CS, Choi HG, Chung SJ et al. (2009). Synergic enhancing-effect of DEET and dodecylamine on the skin permeation of testosterone from a matrix-type transdermal delivery system. Drug Deliv, 16:249–253.
   PubMed Web of Science ®Google Scholar